Compare how in-clinic, burst, and weekly at-home assessment schedules change the sample size a Parkinson’s disease-modifying therapy trial needs to detect an effect.
Explore Koneksa’s digital biomarker conference abstracts and posters, including scientific presentations on digital measures, validation methods, and the use of digital biomarkers in clinical trials. These resources share emerging work presented at scientific and industry conferences and may not have undergone peer review.
Compare how in-clinic, burst, and weekly at-home assessment schedules change the sample size a Parkinson’s disease-modifying therapy trial needs to detect an effect.
See what 3,024 expected pulmonary function tests across three asthma studies reveal about whether patients reliably complete twice-daily spirometry at home.
See how patients and clinicians shaped a composite cardiac biomarker concept for Fabry disease, combining wearables, ECG, diaries, and PROs into one measurement model.